Phase II study of vinorelbine in patients with androgen-independent prostate cancer
Open Access
- 1 June 2001
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 12 (6) , 847-852
- https://doi.org/10.1023/a:1011141611560
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Eligibility and Response Guidelines for Phase II Clinical Trials in Androgen-Independent Prostate Cancer: Recommendations From the Prostate-Specific Antigen Working GroupJournal of Clinical Oncology, 1999
- MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTSJournal of Urology, 1998
- Second-line hormonal therapy for advanced prostate cancer: a shifting paradigm.Journal of Clinical Oncology, 1997
- Cancer statistics, 1997CA: A Cancer Journal for Clinicians, 1997
- The experience with suramin in advanced prostate cancerCancer, 1995
- Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small-cell lung cancer: results of a European multicenter trial including 612 patients.Journal of Clinical Oncology, 1994
- Cytotoxic chemotherapy for advanced hormone-resistant prostate cancerCancer, 1993
- A Review of the Antitumour Activity of Vinorelbine in Breast CancerDrugs, 1992
- A Phase II Study of Navelbine (Vinorelbine) in the Treatment of Non-Small-Cell Lung CancerAmerican Journal of Clinical Oncology, 1991
- Effects of High-Dose Ketoconazole in Patients with Androgen-Independent Prostatic CancerAmerican Journal of Clinical Oncology, 1988